Endo Motoki, Haruyama Yasuo, Takahashi Miyako, Nishiura Chihiro, Kojimahara Noriko, Yamaguchi Naohito
Department of Public Health, Tokyo Women's Medical University, 8-1 Kawadacho, Shinjuku-ku, Tokyo, Japan, 162-8666.
Department of Public Health, Dokkyo Medical University, Tochigi, Japan.
J Cancer Surviv. 2016 Apr;10(2):320-9. doi: 10.1007/s11764-015-0478-3. Epub 2015 Aug 30.
More employees are experiencing a cancer diagnosis during their working-age years, yet there have been no large-scale Japanese studies investigating sick leave due to cancer. We clarified differences in the cumulative partial and full return to work (RTW) rates between different cancer types among Japanese cancer survivors.
Data on Japanese employees who experienced an episode of sick leave due to clinically certified cancer diagnosed between 1 January 2000 and 31 December 2011 were obtained from an occupational health register. Subject outcomes within the 365-day period following their initial day of sick leave were utilized for this study. We investigated the cumulative partial/full and full RTW rates by using survival analysis with competing risks and predictors of time to RTW by a Fine-Gray proportional hazard regression model.
One thousand two hundred seventy-eight subjects (1033 males and 245 females) experienced their first episode of sick leave due to cancer during the 12-year follow-up period. Of the subjects, 47.1% returned to work full time within 6 months of their initial day of sick leave absence, and 62.3% by 12 months. The cumulative RTW rate varied significantly by cancer type. There were considerable differences in the range of cumulative full RTW rates between the two categories ("lower full RTW rate" groups ("lung," "hepatic, pancreatic," "esophageal," and "blood" cancer groups) vs. "higher full RTW rate" groups ("gastric," "intestinal," "breast," "female genital," "male genital," "urinary"): 6.3 to 14.3% vs. 11.4 to 28.3% at 60 days, 10.6 to 22.4% vs. 27.0 to 50.0% at 120 days, 21.3 to 34.7% vs. 38.5 to 65.4% at 180 days, 34.3 to 42.9% vs. 66.0 to 79.5% at 365 days). Additionally, older age may be associated with a longer time to full RTW.
More than half of the subjects returned to work full-time within the 365-day period following their initial day of sick leave, with cumulative RTW rates varying by cancer type. Older employees may require a longer time to full RTW.
It is very important for companies (especially small- and medium-sized companies) to establish and improve their RTW support system for cancer survivors, with knowledge that the median time to RTW is expected to be at least a few months.
越来越多的员工在工作年龄被诊断出患有癌症,但尚未有大规模的日本研究调查因癌症导致的病假情况。我们阐明了日本癌症幸存者中不同癌症类型之间累积部分和完全重返工作岗位(RTW)率的差异。
从职业健康登记处获取2000年1月1日至2011年12月31日期间因临床确诊癌症而经历病假的日本员工的数据。本研究使用了他们病假首日之后365天内的受试者结果。我们通过竞争风险生存分析和Fine-Gray比例风险回归模型来研究累积部分/完全和完全RTW率以及RTW时间的预测因素。
在12年的随访期内,1278名受试者(1033名男性和245名女性)首次因癌症经历病假。其中,47.1%的受试者在病假首日之后6个月内全职重返工作岗位,到12个月时这一比例为62.3%。累积RTW率因癌症类型而异。两类之间(“较低完全RTW率”组(“肺癌”、“肝癌、胰腺癌”、“食管癌”和“血液癌”组)与“较高完全RTW率”组(“胃癌”、“肠癌”、“乳腺癌”、“女性生殖系统癌”、“男性生殖系统癌”、“泌尿系统癌”))的累积完全RTW率范围存在显著差异:60天时为6.3%至14.3% 对 11.4%至28.3%,120天时为10.6%至22.4% 对 27.0%至50.0%,180天时为21.3%至34.7% 对 38.5%至65.4%,365天时为34.3%至42.9% 对 66.0%至79.5%。此外,年龄较大可能与完全RTW的时间较长有关。
超过一半的受试者在病假首日之后的365天内全职重返工作岗位,累积RTW率因癌症类型而异。年龄较大的员工可能需要更长时间才能完全RTW。
公司(尤其是中小企业)了解到RTW的中位时间预计至少为几个月,因此为癌症幸存者建立和完善其RTW支持系统非常重要。